EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS


Rijckborst V., Hansenu B. E. , Cakaloglu Y., Ferenci P., Tabak F. , Akdogan M., ...More

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 14 - 18 April 2010, vol.52 identifier